Webinars
Imaging in Clinical Trials - An Overview of the New FDA Guidance and its Impact
Part 2
Thursday, February 23, 2012 11AM-12PM ET
| Speakers for this Event: | Colin G. Miller, Ph.D., F.I.C.R., CSci – Senior Vice President of Medical Affairs |
| Jennifer A. Minko – Director, Clinical Operations | |
| Moderator: | Harris A. Ahmad, M.D. – Associate Medical Director of Medical Affairs |
The FDA has recently issued a draft Guidance for Industry on Standards for Clinical Trial Imaging Endpoints. This guidance describes procedures recommended for interpreting and collecting medical images in clinical trials. This webinar is the second in the series on this topic and follows up by answering some of the many questions that have been asked about the practical implications.
Since the last webinar, representatives from the FDA presented updates on this guidance to the extended Pharmaceutical Imaging Group. BioClinica is a member of this group and the key updates from the FDA will be disseminated and discussed.
The New FDA Draft Guidances – What it means to me as a Site, a CRA and a Data Manager
On-Demand Webcast
| Speakers for this Event: | Jonathan Andrus – Vice President, Data Management and Quality |
The FDA has recently issued draft guidances for Industry on Standards for Clinical eSource and Risk-Based Approaches to monitoring which have a broad impact on almost all facets of the clinical trial management. This webinar series will discuss the impact of recent FDA guidances on industry and approaches to prepare to implement new strategies.
Leveraging SharePoint to Maximize CTMS Adoption and Flexibility
On-Demand Webcast
| Speakers for this Event: | Les Jordan, CTO - Life Sciences Industry Unit Microsoft |
| Bob Leonard, Chief Information Officer - Harvard Clinical Research Institute |